In an opinion article, investigators argue that gene therapies may not achieve their full potential if the innate inflammation in Duchenne muscular dystrophy is not effectively managed.

The study uncovers how ovarian ECM tropism influences endometriotic cell adhesion, paving the way for novel strategies to ...

Introduction The global prevalence of chronic obstructive pulmonary disease (COPD) is increasing, and it has become a major public health burden worldwide, including in Vietnam. A large body of ...

Chronic kidney disease (CKD) is typically associated with severe fibrosis, the exact pathogenesis of which remains unclear.

Nerandomilast significantly reduces the decline in forced vital capacity in adults with progressive pulmonary fibrosis over 52 weeks, thereby slowing the progression of the condition.

The mother of a 14-year-old boy living with cystic fibrosis is calling for greater awareness over the impact of the rare genetic condition.

Liver fibrosis articles from across Nature Portfolio Liver fibrosis is the liver's response to injury, in which excess extracellular matrix is deposited. In most cases, liver fibrosis is the ...

Boehringer drug scores in another pulmonary fibrosis trial Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings.

Cystic fibrosis (CF) caused by a gene that doesn’t work properly. Learn what genetic testing can tell you about this faulty gene, and what your next steps may be.

There’s more than one way to test for Cystic Fibrosis (CF). Here’s how a diagnosis of this genetic disease can be made.

Mesenchymal stem cells articles from across Nature Portfolio Mesenchymal stem cells are multipotent adult stem cells that are present in multiple tissues, including umbilical cord, bone marrow and ...

Vertex could be close to a price deal with the NHS over its portfolio of cystic fibrosis drugs, after health ministers wrote to the US firm asking for a conclusion to talks after almost two years ...